Cash flow AB Science

Stocks

AB

FR0010557264

Pharmaceuticals

Market Closed - Euronext Paris 11:55:00 2026-08-18 EDT			5-day change	1st Jan Change
0.7120 ^EUR	-0.97%		-7.65%	-53.65%

08-17	AB Science completes settlement and delivery of its private placement
08-10	AB Science Wraps Up EUR14 Million Private Placements	MT

5b58896bc22988d9b4583176e8.eVA66zoP-qXhCQ5qnfvycruu41owlLGEKnliYKt55lo.CiVZpQtaoJytejk585WcBNXxhQJvpODvUgwKDsA9sTgJAUiADkDP0oRfbQ

Published financial data: AB SCIENCE

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	1.61M	958K	970K	1.07M	1.17M
Total Revenues	1.61M	958K	970K	1.07M	1.17M
Cost of Goods Sold, Total	111K	31K	383K	-176K	196K
Gross Profit	1.5M	927K	587K	1.25M	978K
Selling General & Admin Expenses, Total	4.07M	3.52M	3.54M	3.4M	2.43M
R&D Expenses	11.23M	13.34M	10.48M	3.94M	-2.09M
Other Operating Expenses, Total	15.3M	16.86M	14.02M	7.33M	339K
Operating Income	-13.81M	-15.94M	-13.43M	-6.08M	639K
Interest Expense, Total	-23K	-823K	-1.53M	-1.12M	-1.27M
Interest And Investment Income	-	-	221K	202K	243K
Net Interest Expenses	-23K	-823K	-1.31M	-921K	-1.02M
Currency Exchange Gains (Loss)	-20K	134K	424K	-65K	969K
Other Non Operating Income (Expenses)	-17K	459K	2.33M	-762K	-2.14M
EBT, Excl. Unusual Items	-13.87M	-16.17M	-11.98M	-7.83M	-1.56M
Other Unusual Items	-559K	2.56M	-	-	-
EBT, Incl. Unusual Items	-14.43M	-13.61M	-11.98M	-7.83M	-1.56M
Income Tax Expense	36K	4K	-	-	-
Earnings From Continuing Operations	-14.46M	-13.62M	-11.98M	-7.83M	-1.56M
Net Income to Company	-14.46M	-13.62M	-11.98M	-7.83M	-1.56M
Net Income - (IS)	-14.46M	-13.62M	-11.98M	-7.83M	-1.56M
Net Income to Common Incl Extra Items	-14.46M	-13.62M	-11.98M	-7.83M	-1.56M
Net Income to Common Excl. Extra Items	-14.46M	-13.62M	-11.98M	-7.83M	-1.56M
Per Share Items
Net EPS - Basic	-0.3	-0.29	-0.24	-0.15	-0.03
Basic EPS - Continuing Operations	-0.3	-0.29	-0.24	-0.15	-0.03
Basic Weighted Average Shares Outstanding	47.52M	47.14M	49.66M	53.27M	61.24M
Net EPS - Diluted	-0.3	-0.29	-0.24	-0.15	-0.03
Diluted EPS - Continuing Operations	-0.3	-0.29	-0.24	-0.15	-0.03
Diluted Weighted Average Shares Outstanding	47.52M	47.14M	49.66M	53.27M	61.24M
Normalized Basic EPS	-0.18	-0.21	-0.15	-0.09	-0.02
Normalized Diluted EPS	-0.18	-0.21	-0.15	-0.09	-0.02
Supplemental Items
EBITDA	-13.32M	-15.53M	-12.8M	-5.69M	745K
EBITA	-13.38M	-15.61M	-12.88M	-5.86M	675K
EBIT	-13.81M	-15.94M	-13.43M	-6.08M	639K
EBITDAR	-	-	-	-	-
Total Revenues (As Reported)	1.61M	958K	970K	1.07M	1.17M
Effective Tax Rate - (Ratio)	-0.25	-0.03	-	-	-
Normalized Net Income	-8.67M	-10.1M	-7.49M	-4.89M	-973K
Interest Capitalized	-	-	-	-	-
Interest on Long-Term Debt	-	-	-	-	-
Non-Cash Pension Expense	92K	105K	103K	44K	-28K
Supplemental Operating Expense Items
Marketing Expenses	493K	480K	522K	316K	298K
Selling and Marketing Expenses	493K	480K	522K	316K	298K
General and Administrative Expenses	3.58M	3.04M	3.02M	3.08M	2.13M
Research And Development Expense From Footnotes	15.1M	17.35M	13.93M	6.26M	-234K
Net Rental Expense, Total	-	-	-	-	-
Imputed Operating Lease Interest Expense	-	-	-	-	-
Imputed Operating Lease Depreciation	-	-	-	-	-
Stock-Based Comp., Other (Total)	258K	133K	605K	1.02M	2.09M
Total Stock-Based Compensation	258K	133K	605K	1.02M	2.09M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	8.72M	7.27M	6.07M	7.99M	10.18M
Total Cash And Short Term Investments	8.72M	7.27M	6.07M	7.99M	10.18M
Accounts Receivable, Total	310K	161K	236K	130K	-
Other Receivables	8.3M	12.62M	11.79M	5.36M	3.49M
Total Receivables	8.61M	12.78M	12.03M	5.49M	3.49M
Inventory	141K	456K	336K	184K	145K
Prepaid Expenses	-	-	639K	269K	382K
Other Current Assets, Total	718K	367K	322K	590K	6K
Total Current Assets	18.19M	20.87M	19.39M	14.52M	14.2M
Gross Property Plant And Equipment	2.38M	2.14M	1.59M	1.86M	2.03M
Accumulated Depreciation	-791K	-876K	-801K	-960K	-1.04M
Net Property Plant And Equipment	1.59M	1.27M	785K	899K	996K
Long-term Investments	-	-	-	-	-
Other Intangibles, Total	1.42M	1.63M	1.4M	1.33M	1.57M
Other Long-Term Assets, Total	67K	76K	3.92M	6.43M	7.76M
Total Assets	21.27M	23.84M	25.5M	23.18M	24.52M
Liabilities
Accounts Payable, Total	11.37M	12.25M	11.08M	10.03M	9.3M
Accrued Expenses, Total	4.17M	4.9M	3.96M	3.48M	2.02M
Current Portion of Long-Term Debt	252K	4.33M	1.91M	3.8M	697K
Current Portion of Leases	379K	361K	212K	123K	124K
Current Income Taxes Payable	-	-	564K	501K	499K
Other Current Liabilities	1.31M	1.23M	966K	2.5M	2.17M
Total Current Liabilities	17.48M	23.08M	18.68M	20.43M	14.82M
Long-Term Debt	13.41M	22.35M	16.52M	14M	17.92M
Long-Term Leases	1.04M	697K	382K	541K	708K
Pension & Other Post Retirement Benefits	1.08M	916K	773K	817K	789K
Other Non Current Liabilities	11.46M	12.47M	10.16M	11.14M	7.49M
Total Liabilities	44.47M	59.51M	46.51M	46.93M	41.72M
Common Stock, Total	469K	469K	511K	579K	664K
Additional Paid In Capital	234M	234M	257M	272M	280M
Retained Earnings	-	-	-	-	-
Comprehensive Income and Other	-258M	-270M	-278M	-296M	-298M
Total Common Equity	-23.2M	-35.67M	-21.01M	-23.75M	-17.2M
Total Equity	-23.2M	-35.67M	-21.01M	-23.75M	-17.2M
Total Liabilities And Equity	21.27M	23.84M	25.5M	23.18M	24.52M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	46.6M	46.63M	58.12M	63.89M	73.13M
ECS Total Common Shares Outstanding	46.6M	46.63M	58.12M	63.89M	73.13M
Book Value / Share	-0.5	-0.76	-0.36	-0.37	-0.24
Tangible Book Value	-24.62M	-37.3M	-22.41M	-25.08M	-18.77M
Tangible Book Value Per Share	-0.53	-0.8	-0.39	-0.39	-0.26
Total Debt	15.08M	27.74M	19.02M	18.47M	19.45M
Net Debt	6.35M	20.47M	12.95M	10.48M	9.27M
Debt Equivalent Oper. Leases	-	-	-	-	-
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	8K	103K	1K	-	-
Inventories - Work In Process, Total	102K	295K	410K	427K	485K
Inventories - Finished Goods, Total	31K	58K	339K	635K	552K
Machinery, Total	1.07M	1.19M	1.05M	1.2M	1.21M
Full Time Employees	98	103	51	28	26
Part Time Employees	-	-	6	11	10
Accumulated Allowance for Doubtful Accounts (Supple)	13K	13K	13K	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-14.46M	-13.62M	-11.98M	-7.83M	-1.56M
Depreciation & Amortization - CF	460K	480K	438K	446K	222K
Amortization of Goodwill and Intangible Assets - (CF)	426K	325K	552K	225K	36K
Depreciation & Amortization, Total	886K	805K	990K	671K	258K
Stock-Based Compensation (CF)	258K	133K	605K	1.02M	2.09M
Other Operating Activities, Total	1.7M	-1.96M	-2.06M	614K	-3.16M
Change In Accounts Receivable	-	-	-75K	-	-
Change In Inventories	-	-	120K	-	-
Change In Accounts Payable	-	-	-49K	-	-
Change in Other Net Operating Assets	-5.56M	-2.83M	-4.42M	6.05M	-1.92M
Cash from Operations	-17.18M	-17.47M	-16.87M	525K	-4.29M
Capital Expenditure	-564K	-644K	-345K	-155K	-282K
Sale of Property, Plant, and Equipment	-	-	-	19K	58K
Investment in Marketable and Equity Securities, Total	-	-	-	-	-
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-
Other Investing Activities, Total	-26K	284K	-269K	-	-
Cash from Investing	-590K	-360K	-614K	-136K	-224K
Long-Term Debt Issued, Total	6M	16.57M	6M	-	-
Total Debt Issued	6M	16.57M	6M	-	-
Long-Term Debt Repaid, Total	-4.31M	-188K	-1.2M	-2.36M	-1.92M
Total Debt Repaid	-4.31M	-188K	-1.2M	-2.36M	-1.92M
Issuance of Common Stock	4.16M	4K	11.47M	3.89M	8.61M
Other Financing Activities, Total	-	1K	-1K	-1K	-
Cash from Financing	5.84M	16.39M	16.27M	1.53M	6.69M
Foreign Exchange Rate Adjustments	-14K	-11K	8K	-	-
Miscellaneous Cash Flow Adjustments	-1K	-1K	-	-	-
Net Change in Cash	-11.94M	-1.45M	-1.2M	1.92M	2.18M
Supplemental Items
Cash Income Tax Paid (Refund)	-36K	-4K	-	-	-
Levered Free Cash Flow	-12.87M	-12.79M	-9.64M	3.76M	1.68M
Unlevered Free Cash Flow	-12.86M	-12.27M	-8.68M	4.46M	2.47M
Change In Net Working Capital	4.81M	2.6M	1.54M	-6.73M	-4K
Net Debt Issued / Repaid	1.69M	16.39M	4.8M	-2.36M	-1.92M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-33.87	-44.16	-34.02	-15.62	1.67
Return on Total Capital	222.19	124.1	169.13	104.48	-26.35
Return On Equity %	67.67	46.26	42.29	34.99	7.6
Return on Common Equity	67.67	46.26	42.29	34.99	7.6
Margin Analysis
Gross Profit Margin %	93.09	96.76	60.52	116.42	83.3
SG&A Margin	253.33	367.43	364.85	316.7	206.9
EBITDA Margin %	-828.62	-1.62K	-1.32K	-530.69	63.46
EBITA Margin %	-832.73	-1.63K	-1.33K	-546.46	57.5
EBIT Margin %	-859.24	-1.66K	-1.38K	-567.44	54.43
Income From Continuing Operations Margin %	-900	-1.42K	-1.24K	-730.5	-132.62
Net Income Margin %	-900	-1.42K	-1.24K	-730.5	-132.62
Net Avail. For Common Margin %	-900	-1.42K	-1.24K	-730.5	-132.62
Normalized Net Income Margin	-539.36	-1.05K	-772.23	-456.56	-82.89
Levered Free Cash Flow Margin	-800.89	-1.33K	-993.56	350.4	143.03
Unlevered Free Cash Flow Margin	-800	-1.28K	-895.17	415.87	210.42
Asset Turnover
Asset Turnover	0.06	0.04	0.04	0.04	0.05
Fixed Assets Turnover	0.94	0.67	0.95	1.27	1.24
Receivables Turnover (Average Receivables)	4.83	4.07	4.89	5.86	-
Inventory Turnover (Average Inventory)	1.01	0.1	0.97	-0.68	1.19
Short Term Liquidity
Current Ratio	1.04	0.9	1.04	0.71	0.96
Quick Ratio	0.99	0.87	0.97	0.66	0.92
Operating Cash Flow to Current Liabilities	-0.98	-0.76	-0.9	0.03	-0.29
Days Sales Outstanding (Average Receivables)	75.52	89.73	74.69	62.48	-
Days Outstanding Inventory (Average Inventory)	361.71	3.51K	377.39	-540.68	306.34
Average Days Payable Outstanding	26.01K	12.46K	16.18K	-11.77K	22.47K
Cash Conversion Cycle (Average Days)	-25.57K	-8.85K	-15.73K	11.3K	-
Long Term Solvency
Total Debt/Equity	-64.98	-77.77	-90.5	-77.76	-113.09
Total Debt / Total Capital	-185.58	-349.81	-953.13	-349.63	863.68
LT Debt/Equity	-62.26	-64.61	-80.42	-61.22	-108.32
Long-Term Debt / Total Capital	-177.82	-290.61	-846.97	-275.28	827.22
Total Liabilities / Total Assets	209.06	249.62	182.4	202.5	170.12
EBIT / Interest Expense	-600.35	-19.37	-8.79	-5.42	0.5
EBITDA / Interest Expense	-561.83	-18.39	-8.15	-4.82	0.71
(EBITDA - Capex) / Interest Expense	-586.35	-19.17	-8.37	-4.96	0.49
Total Debt / EBITDA	-1.17	-1.83	-1.53	-3.41	21.68
Net Debt / EBITDA	-0.49	-1.35	-1.04	-1.94	10.34
Total Debt / (EBITDA - Capex)	-1.12	-1.76	-1.49	-3.32	31.63
Net Debt / (EBITDA - Capex)	-0.47	-1.3	-1.01	-1.88	15.07
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	1.52	-40.39	1.25	10.52	9.51
Gross Profit, 1 Yr. Growth %	-1.19	-38.03	-36.68	112.61	-21.63
EBITDA, 1 Yr. Growth %	-7.55	16.61	-17.59	-55.54	-113.1
EBITA, 1 Yr. Growth %	-7.58	16.67	-17.52	-54.51	-111.52
EBIT, 1 Yr. Growth %	-6.38	15.43	-15.74	-54.7	-110.5
Earnings From Cont. Operations, 1 Yr. Growth %	-3.87	-5.86	-11.97	-34.66	-80.12
Net Income, 1 Yr. Growth %	-3.87	-5.86	-11.97	-34.66	-80.12
Normalized Net Income, 1 Yr. Growth %	-7.77	12.07	-11.95	-34.66	-80.12
Diluted EPS Before Extra, 1 Yr. Growth %	-10.53	-4.72	-16.79	-37.84	-80
Accounts Receivable, 1 Yr. Growth %	-12.68	-48.06	46.58	-44.92	-
Inventory, 1 Yr. Growth %	78.48	223.4	-26.32	-45.24	-21.2
Net Property, Plant and Equip., 1 Yr. Growth %	-12.66	-20.51	-38.04	14.52	10.79
Total Assets, 1 Yr. Growth %	-28.35	12.08	6.95	-9.11	5.83
Tangible Book Value, 1 Yr. Growth %	17.13	51.48	-39.91	11.9	-25.18
Common Equity, 1 Yr. Growth %	18.67	53.76	-41.1	13.06	-27.6
Cash From Operations, 1 Yr. Growth %	27.14	1.71	-3.43	-103.11	-916.95
Capital Expenditures, 1 Yr. Growth %	52.43	14.18	-46.43	-55.07	81.94
Levered Free Cash Flow, 1 Yr. Growth %	73.17	-0.66	-24.62	-138.98	-55.3
Unlevered Free Cash Flow, 1 Yr. Growth %	74.69	-4.55	-29.24	-151.34	-44.59
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	1.14	-22.21	-22.31	5.78	10.01
Gross Profit, 2 Yr. CAGR %	3.74	-21.75	-37.36	16.03	29.08
EBITDA, 2 Yr. CAGR %	-11.42	3.83	-1.97	-39.47	-75.87
EBITA, 2 Yr. CAGR %	-11.39	3.84	-1.9	-38.75	-77.1
EBIT, 2 Yr. CAGR %	-11.11	3.95	-1.38	-38.22	-78.19
Earnings From Cont. Operations, 2 Yr. CAGR %	-18.45	-4.87	-8.97	-24.16	-63.96
Net Income, 2 Yr. CAGR %	-18.45	-4.87	-8.97	-24.16	-63.96
Normalized Net Income, 2 Yr. CAGR %	-20.14	3.69	-8.86	-24.15	-63.96
Diluted EPS Before Extra, 2 Yr. CAGR %	-25.74	-7.67	-10.96	-28.08	-64.74
Accounts Receivable, 2 Yr. CAGR %	25.44	-32.66	-12.75	-10.14	-
Inventory, 2 Yr. CAGR %	-21.7	140.25	54.37	-36.48	-34.31
Net Property, Plant and Equip., 2 Yr. CAGR %	-14.33	-16.68	-29.82	-15.77	12.64
Total Assets, 2 Yr. CAGR %	9.5	-10.39	9.49	-1.41	-1.93
Tangible Book Value, 2 Yr. CAGR %	-6.64	33.2	-4.59	-18	-8.5
Common Equity, 2 Yr. CAGR %	-7.01	35.08	-4.83	-18.4	-9.53
Cash From Operations, 2 Yr. CAGR %	6.46	13.71	-0.9	-82.67	-49.58
Capital Expenditures, 2 Yr. CAGR %	20.26	31.93	-21.79	-50.94	-9.59
Levered Free Cash Flow, 2 Yr. CAGR %	15.85	31.16	-13.47	-45.8	-58.26
Unlevered Free Cash Flow, 2 Yr. CAGR %	15.85	29.13	-17.82	-39.73	-46.66
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-1.88	-15.2	-15.06	-12.62	7.01
Gross Profit, 3 Yr. CAGR %	0.98	-12.63	-27.08	-5.86	1.8
EBITDA, 3 Yr. CAGR %	-22.2	-2.91	-3.86	-24.68	-63.66
EBITA, 3 Yr. CAGR %	-22.15	-2.88	-3.84	-24.07	-64.9
EBIT, 3 Yr. CAGR %	-21.86	-3.02	-3.08	-23.91	-65.77
Earnings From Cont. Operations, 3 Yr. CAGR %	-17.82	-14.45	-7.3	-18.49	-51.46
Net Income, 3 Yr. CAGR %	-17.82	-14.45	-7.3	-18.49	-51.46
Normalized Net Income, 3 Yr. CAGR %	-18.96	-9.4	-7.28	-18.43	-51.46
Diluted EPS Before Extra, 3 Yr. CAGR %	-23.88	-19.31	-10.82	-21.01	-53.06
Accounts Receivable, 3 Yr. CAGR %	9.52	-6.51	-12.72	-25.15	-
Inventory, 3 Yr. CAGR %	-2.69	25.63	62.02	9.28	-31.74
Net Property, Plant and Equip., 3 Yr. CAGR %	118.41	-16.45	-24.51	-17.38	-7.71
Total Assets, 3 Yr. CAGR %	-1.84	10.35	-4.94	2.9	0.95
Tangible Book Value, 3 Yr. CAGR %	14.19	9.71	2.16	0.62	-20.46
Common Equity, 3 Yr. CAGR %	15.74	9.96	2.43	0.79	-21.59
Cash From Operations, 3 Yr. CAGR %	-13.77	4.85	7.68	-68.73	-37.38
Capital Expenditures, 3 Yr. CAGR %	5.23	18.2	-2.3	-34.98	-24.06
Levered Free Cash Flow, 3 Yr. CAGR %	-8.08	10.07	9.05	-33.67	-49.17
Unlevered Free Cash Flow, 3 Yr. CAGR %	-8.12	8.61	5.67	-29.74	-41.39
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	1.28	-11.24	-10.63	-7.36	-5.8
Gross Profit, 5 Yr. CAGR %	7.23	-10.54	-16.58	-2.13	-8.37
EBITDA, 5 Yr. CAGR %	-14.76	-11.1	-14.66	-19.63	-44.7
EBITA, 5 Yr. CAGR %	-14.73	-11.06	-14.61	-19.23	-45.84
EBIT, 5 Yr. CAGR %	-14.49	-10.91	-14.24	-19.03	-46.62
Earnings From Cont. Operations, 5 Yr. CAGR %	-12.19	-12.88	-14.39	-18.48	-36.47
Net Income, 5 Yr. CAGR %	-12.19	-12.88	-14.39	-18.48	-36.47
Normalized Net Income, 5 Yr. CAGR %	-12.93	-9.82	-14.39	-18.47	-36.46
Diluted EPS Before Extra, 5 Yr. CAGR %	-17.09	-17.39	-18.95	-22.94	-38.47
Accounts Receivable, 5 Yr. CAGR %	-15.77	-24.61	0	-7.98	-
Inventory, 5 Yr. CAGR %	1.02	23.46	17.04	-4.36	12.91
Net Property, Plant and Equip., 5 Yr. CAGR %	49.42	49.26	38.69	-16.17	-11.41
Total Assets, 5 Yr. CAGR %	-10.96	-13.97	2.54	5.49	-3.75
Tangible Book Value, 5 Yr. CAGR %	31.19	32.9	6.27	-2.35	-2.24
Common Equity, 5 Yr. CAGR %	37.59	27.15	7.03	-2.41	-2.53
Cash From Operations, 5 Yr. CAGR %	-12.52	-5.26	-8.84	-48.96	-20.51
Capital Expenditures, 5 Yr. CAGR %	1.48	5.07	-6.55	-16.85	-5.29
Levered Free Cash Flow, 5 Yr. CAGR %	-11.24	-0.07	-10.28	-17.09	-25.73
Unlevered Free Cash Flow, 5 Yr. CAGR %	-11.04	-0.89	-12.13	-14.18	-19.61